ClinicalTrials.gov record
Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women
ClinicalTrials.gov ID: NCT00683800
Public ClinicalTrials.gov record NCT00683800. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Study Assessing The Safety And Efficacy Of DVS SR For The Treatment Of Vasomotor Symptoms Associated With Menopause
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the efficacy and safety of Desvenlafaxine Succinate (DVS) Sustained Release (SR), in comparison to placebo for the treatment of Vasomotor Symptoms (VMS) in menopausal women.
Study identification
- NCT ID
- NCT00683800
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,186 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2008 (Type not available)
- Primary completion
- May 2010 (Actual)
- Completion
- May 2010 (Actual)
- Last update posted
- Aug 17, 2011
2008 – 2010
United States locations
- U.S. sites
- 102
- U.S. states
- 41
- U.S. cities
- 89
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35235 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36608 | — |
| Pfizer Investigational Site | Montgomery | Alabama | 36106 | — |
| Pfizer Investigational Site | Glendale | Arizona | 85308 | — |
| Pfizer Investigational Site | Peoria | Arizona | 85381 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85710 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85712 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85715 | — |
| Pfizer Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72205 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72223 | — |
| Pfizer Investigational Site | San Diego | California | 92103 | — |
| Pfizer Investigational Site | San Diego | California | 92108 | — |
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | Vista | California | 92083 | — |
| Pfizer Investigational Site | Walnut Creek | California | 94598 | — |
| Pfizer Investigational Site | Colorado Springs | Colorado | 80910 | — |
| Pfizer Investigational Site | Denver | Colorado | 80218 | — |
| Pfizer Investigational Site | Englewood | Colorado | 80112 | — |
| Pfizer Investigational Site | Longmont | Colorado | 80501 | — |
| Pfizer Investigational Site | New London | Connecticut | 06320 | — |
| Pfizer Investigational Site | Newark | Delaware | 19713 | — |
| Pfizer Investigational Site | Brooksville | Florida | 34601 | — |
| Pfizer Investigational Site | Clearwater | Florida | 33759 | — |
| Pfizer Investigational Site | Clearwater | Florida | 33761 | — |
| Pfizer Investigational Site | Daytona Beach | Florida | 32114 | — |
| Pfizer Investigational Site | Fort Myers | Florida | 33916 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32610 | — |
| Pfizer Investigational Site | Lake Worth | Florida | 33461 | — |
| Pfizer Investigational Site | New Port Richey | Florida | 34652 | — |
| Pfizer Investigational Site | Palm Harbor | Florida | 34684 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33024 | — |
| Pfizer Investigational Site | South Miami | Florida | 33143 | — |
| Pfizer Investigational Site | Tampa | Florida | 33606 | — |
| Pfizer Investigational Site | West Palm Beach | Florida | 33409 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30319 | — |
| Pfizer Investigational Site | Savannah | Georgia | 31406 | — |
| Pfizer Investigational Site | Boise | Idaho | 83702 | — |
| Pfizer Investigational Site | Idaho Falls | Idaho | 83404 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46202 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46260 | — |
| Pfizer Investigational Site | South Bend | Indiana | 46601 | — |
| Pfizer Investigational Site | Overland Park | Kansas | 66210 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40509 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40291 | — |
| Pfizer Investigational Site | New Orleans | Louisiana | 70114 | — |
| Pfizer Investigational Site | Scarborough | Maine | 04074 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48106 | — |
| Pfizer Investigational Site | Brooklyn Center | Minnesota | 55430 | — |
| Pfizer Investigational Site | Creve Coeur | Missouri | 63141 | — |
| Pfizer Investigational Site | Billings | Montana | 59101 | — |
| Pfizer Investigational Site | Billings | Montana | 59102 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68510 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89109 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89146 | — |
| Pfizer Investigational Site | Reno | Nevada | 89502 | — |
| Pfizer Investigational Site | Lebanon | New Hampshire | 03756 | — |
| Pfizer Investigational Site | New Brunswick | New Jersey | 08901 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Pfizer Investigational Site | New York | New York | 10032 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Bismarck | North Dakota | 58501 | — |
| Pfizer Investigational Site | Fargo | North Dakota | 58104 | — |
| Pfizer Investigational Site | Jamestown | North Dakota | 58401 | — |
| Pfizer Investigational Site | Akron | Ohio | 44311 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45267-0457 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44122 | — |
| Pfizer Investigational Site | Englewood | Ohio | 45322 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112-4481 | — |
| Pfizer Investigational Site | Eugene | Oregon | 97401 | — |
| Pfizer Investigational Site | Medford | Oregon | 97504 | — |
| Pfizer Investigational Site | Erie | Pennsylvania | 16502 | — |
| Pfizer Investigational Site | Erie | Pennsylvania | 16507-1411 | — |
| Pfizer Investigational Site | Jenkintown | Pennsylvania | 19046 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15206 | — |
| Pfizer Investigational Site | Wexford | Pennsylvania | 15090 | — |
| Pfizer Investigational Site | Warwick | Rhode Island | 02886 | — |
| Pfizer Investigational Site | Greer | South Carolina | 29651 | — |
| Pfizer Investigational Site | Hilton Head Island | South Carolina | 29926 | — |
| Pfizer Investigational Site | Sioux Falls | South Dakota | 57104 | — |
| Pfizer Investigational Site | Sioux Falls | South Dakota | 57105 | — |
| Pfizer Investigational Site | Watertown | South Dakota | 57201 | — |
| Pfizer Investigational Site | Chattanooga | Tennessee | 37404 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37920 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37203 | — |
| Pfizer Investigational Site | Dallas | Texas | 75234 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Midland | Texas | 79705 | — |
| Pfizer Investigational Site | Plano | Texas | 75093 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | Waco | Texas | 76712 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84117 | — |
| Pfizer Investigational Site | Sandy City | Utah | 84070 | — |
| Pfizer Investigational Site | Burlington | Vermont | 05401 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23502 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23507 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
| Pfizer Investigational Site | Seattle | Washington | 98105 | — |
| Pfizer Investigational Site | Menomonee Falls | Wisconsin | 53051 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00683800, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 17, 2011 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00683800 live on ClinicalTrials.gov.